In this episode we have a chat with Dr Charley Budgeon, biostatistician and lecturer at the School of Population and Global Health at UWA. Charley talks us through her education and career, and a long-term collaboration with Dr Stefan Mark Nidorf as the lead biostatistician analysing data for trials that he has led investigating whether anti-inflammatory drug Colchicine could be used to reduce the risk of cardiovascular events in people with chronic cardiovascular disease. This work has resulted in the publication of a recent paper Colchicine in Patients with Chronic Coronary Disease in the top-ranked Medical Journal, The New England Journal of Medicine. Charley discusses how the study was conducted, and the many collaborators and challenges involved in conducting the study across 2 countries, and using data that were not originally in English. We also talk about life as an academic and the importance of collaborations and managing sometimes tricky relationships. We both enjoyed the conversation with Charley and hope you do too.
You can find the recent paper Charley had published in the New England Journal of Medicine here: https://www.nejm.org/doi/full/10.1056/NEJMoa2021372
You can read more about Charley and her work here: https://research-repository.uwa.edu.au/en/persons/charley-budgeon
You can find information about the original LoDoCo study here: https://pubmed.ncbi.nlm.nih.gov/23265346/
As always, if you want to get in touch with the podcast, you can contact us at: meaningofhealth@outlook.com or via twitter @healthmeanswhat
